Regarding FADS1, liver mRNA gene expression level was similar in NASH compared to control group and only a slight decrease was observed in NASH compared to NAFL2 group (Supplemental Fig. S5e). This evidence concerns the gene FADS1 and metabolic dysfunction-associated steatohepatitis.